Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Anna Nicolazzi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Medicine|October 9, 2015
Leukocyte Activation in Obese Patients: Effect of Bariatric SurgeryDaniele Minervino, Daniela Gumiero, Maria Anna Nicolazzi, et al.
International Journal of Molecular Sciences|January 25, 2025
Residual Traditional Risk in Non-Traditional Atherosclerotic DiseasesFederico Biscetti, Giorgia Polito, Maria Margherita Rando, et al.
International Journal of Molecular Sciences|August 26, 2022
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?Enrica Rossini, Federico Biscetti, Maria Margherita Rando, et al.
European Journal of Internal Medicine|October 8, 2025
Prognostic role of TAPSE/PASP ratio among older patients with acute heart failure and preserved ejection fractionGiuseppe De Matteis, Amato Serra, Maria Livia Burzo, et al.
International Journal of Endocrinology|November 12, 2020
Corrigendum to "Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity"Antonio Mancini, Angela Maria Rita Favuzzi, Carmine Bruno, et al.
Frontiers in Endocrinology|June 2, 2020
Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial DysfunctionCarmine Bruno, Andrea Silvestrini, Rodolfo Calarco, et al.
International Journal of Endocrinology|May 16, 2020
Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant CapacityAntonio Mancini, Angela Maria Rita Fuvuzzi, Carmine Bruno, et al.
Internal and Emergency Medicine|September 3, 2024
Clinical characteristics and prognostic impact of atrial fibrillation among older patients with heart failure with preserved ejection fraction hospitalized for acute heart failureGiuseppe De Matteis, Maria Livia Burzo, Amato Serra, et al.
Cardiovascular Diabetology|June 13, 2026
Apolipoprotein B100 predicts cardiovascular and limb events in type 2 diabetes patients with chronic limb-threatening ischemiaFederico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, et al.
Cardiovascular Diabetology|July 10, 2025
Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemiaFederico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Medicine|October 9, 2015
Leukocyte Activation in Obese Patients: Effect of Bariatric SurgeryDaniele Minervino, Daniela Gumiero, Maria Anna Nicolazzi, et al.
International Journal of Molecular Sciences|January 25, 2025
Residual Traditional Risk in Non-Traditional Atherosclerotic DiseasesFederico Biscetti, Giorgia Polito, Maria Margherita Rando, et al.
International Journal of Molecular Sciences|August 26, 2022
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?Enrica Rossini, Federico Biscetti, Maria Margherita Rando, et al.
European Journal of Internal Medicine|October 8, 2025
Prognostic role of TAPSE/PASP ratio among older patients with acute heart failure and preserved ejection fractionGiuseppe De Matteis, Amato Serra, Maria Livia Burzo, et al.
International Journal of Endocrinology|November 12, 2020
Corrigendum to "Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity"Antonio Mancini, Angela Maria Rita Favuzzi, Carmine Bruno, et al.
Frontiers in Endocrinology|June 2, 2020
Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial DysfunctionCarmine Bruno, Andrea Silvestrini, Rodolfo Calarco, et al.
International Journal of Endocrinology|May 16, 2020
Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant CapacityAntonio Mancini, Angela Maria Rita Fuvuzzi, Carmine Bruno, et al.
Internal and Emergency Medicine|September 3, 2024
Clinical characteristics and prognostic impact of atrial fibrillation among older patients with heart failure with preserved ejection fraction hospitalized for acute heart failureGiuseppe De Matteis, Maria Livia Burzo, Amato Serra, et al.
Cardiovascular Diabetology|June 13, 2026
Apolipoprotein B100 predicts cardiovascular and limb events in type 2 diabetes patients with chronic limb-threatening ischemiaFederico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, et al.
Cardiovascular Diabetology|July 10, 2025
Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemiaFederico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, et al.
Pageof 3